Source: Eur Respir J, 53 (4) 1900515; 10.1183/13993003.00515-2019
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Brian D. Hobbs, Kelan G. Tantisira. MicroRNAs in COPD: small molecules with big potential. Eur Respir J, 53 (4) 1900515; 10.1183/13993003.00515-2019

Member's Comments

No comment yet.

Related content which might interest you: MicroRNAs as future therapeutic targets in COPD? Source: Eur Respir J, 49 (5) 1700431; 10.1183/13993003.00431-2017 Year: 2017 MicroRNAs and pulmonary hypertension Source: Eur Respir J 2014; 43: 313-314 Year: 2004 MicroRNAs in the pathogenesis of pulmonary fibrosis Source: International Congress 2015 – PG8 Airway and lung fibrosis Year: 2015 Unravelling the complexity of COPD by microRNAs: it's a small world after all Source: Eur Respir J 2015; 46: 807-818 Year: 2015 MicroRNAs in serum of Interstitial lung diseases patients. Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020 Exosomal microRNAs in the lung: eliciting long-term intercellular communication? Source: International Congress 2018 – Intercellular communication in tissue remodelling Year: 2018 Late Breaking Abstract - Differentially expressed exosomal miRNAs target key inflammatory pathways in COPD. Source: International Congress 2018 – Advanced profiling of immune cells in chronic lung diseases Year: 2018 MicroRNAs in human lung cancer and human lung embryogenesis Source: Eur Respir J 2007; 30: Suppl. 51, 428s Year: 2007 Sphingolipids in COPD Source: Eur Respir Rev, 28 (154) 190047; 10.1183/16000617.0047-2019 Year: 2019 Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development? Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Non-coding RNA as functional player and molecular marker in lung cancer Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011 MicroRNAs in serum of post primary TB patients. Source: International Congress 2018 – The immune response to tuberculosis: development of biomarkers and diagnostic tools Year: 2018 Small airways, big challenge Source: Eur Respir Rev 2011; 20: 1-2 Year: 2011 Investigating circulating microRNAs as potential biomarkers of quadriceps weakness in COPD Source: Annual Congress 2011 - Skeletal muscle weakness in COPD: physical (in)activity and biological markers Year: 2011 Experimental discovery of small regulatory RNAs in M. tuberculosis: A genome-wide analysis Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases Year: 2010 Fibrocytes: potential new therapeutic targets for pulmonary hypertension? Source: Eur Respir J 2010; 36: 1232-1235 Year: 2010 Generation of small molecules targeting hypoxia inducible factors Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018 Potential angiogenic biomarkers in patients with non small cell lung cancer: Possible implications Source: Annual Congress 2012 - New biomarkers for lung cancer Year: 2012